Advertisement

Topics

Biomarker as Indicator of Lower Respiratory Tract Infections Improving With Antibiotic Treatment

11:53 EST 14 Feb 2018 | Virgo Publishing

A new clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aims to determine whether low blood levels of the protein procalcitonin can reliably indicate whether a person’s lower respiratory tract infection will improve with antibiotic treatment. Lower

Original Article: Biomarker as Indicator of Lower Respiratory Tract Infections Improving With Antibiotic Treatment

NEXT ARTICLE

More From BioPortfolio on "Biomarker as Indicator of Lower Respiratory Tract Infections Improving With Antibiotic Treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...